Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
The Bamboo Works

With Zero Revenue, Laekna Plays Chicken-And-Egg Game With Investors

Key Takeaways:

  • Laekna is seeking a Hong Kong IPO to raise funds to accelerate the commercialize two core products licensed from Novartis
  • The company currently is not generating any sale, with most of its products in early stages of development
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.